{{refimprove|date=September 2011}}
{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 457636417
| IUPAC_name = 9-fluoro-11,17-dihydroxy-17- (2-hydroxyacetyl)- 10,13-dimethyl- 1,2,6,7,8,9,10,11,12, 13,14,15,16,17- tetradecahydrocyclopenta[a]phenanthren-3-one
| image = fludrocortisone structure.png
| image2 = Fludrocortisone-from-xtal-1972-3D-balls.png
<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|monograph|florinef-acetate}}
| pregnancy_category = C
| legal_status =  
| routes_of_administration = oral

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound = High
| metabolism = Hepatic
| elimination_half-life = 3.5 hours

<!--Identifiers-->
| CASNo_Ref = {{cascite|correct|CAS}}
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 127-31-1
| ATC_prefix = H02
| ATC_suffix = AA02
| ATC_supplemental =  
| PubChem = 31378
| IUPHAR_ligand = 2873
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
 | DrugBank = DB00687
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 29111
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = U0476M545B
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07967
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 50885
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1201388

<!--Chemical data-->
 | C=21 | H=29 | F=1 | O=5 
| molecular_weight = 380.45 g/mol
| smiles = O=C(CO)[C@]3(O)[C@]2(C[C@H](O)[C@]4(F)[C@@]1(/C(=C\C(=O)CC1)CC[C@H]4[C@@H]2CC3)C)C
| InChI = 1/C21H29FO5/c1-18-7-5-13(24)9-12(18)3-4-15-14-6-8-20(27,17(26)11-23)19(14,2)10-16(25)21(15,18)22/h9,14-16,23,25,27H,3-8,10-11H2,1-2H3/t14-,15-,16-,18-,19-,20-,21-/m0/s1
| InChIKey = AAXVEMMRQDVLJB-BULBTXNYBK
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C21H29FO5/c1-18-7-5-13(24)9-12(18)3-4-15-14-6-8-20(27,17(26)11-23)19(14,2)10-16(25)21(15,18)22/h9,14-16,23,25,27H,3-8,10-11H2,1-2H3/t14-,15-,16-,18-,19-,20-,21-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = AAXVEMMRQDVLJB-BULBTXNYSA-N
}}

'''Fludrocortisone''' (also called '''9α-fluorocortisol''' or '''9α-fluorohydrocortisone''') is a synthetic [[corticosteroid]] with moderate [[glucocorticoid]] potency and much greater [[mineralocorticoid]] potency.  The brand name in the U.S. and Canada is '''Florinef'''. 

==Uses==
Fludrocortisone has been used in the treatment of cerebral salt wasting.<ref name="pmid17101713">{{cite journal |author=Taplin CE, Cowell CT, Silink M, Ambler GR |title=Fludrocortisone therapy in cerebral salt wasting |journal=Pediatrics |volume=118 |issue=6 |pages=e1904–8 |year=2006 |month=December |pmid=17101713 |doi=10.1542/peds.2006-0702 |url=http://pediatrics.aappublications.org/cgi/pmidlookup?view=long&pmid=17101713}}</ref>  It is used primarily to replace the missing hormone [[aldosterone]] in various forms of [[adrenal insufficiency]] such as [[Addison's disease]] and the classic salt wasting ([[21-hydroxylase deficiency]]) form of [[congenital adrenal hyperplasia]].  Fludrocortisone is the first line of treatment for [[orthostatic intolerance]] and [[Postural Tachycardia Syndrome]] as well.{{Citation needed|date=April 2013}}

Fludrocortisone is also a confirmation test for diagnosing [[Conns Syndrome]] (aldosterone producing-adrenal adenoma), the fludrocortisone suppression test. Loading the patient with fludrocortisone would suppress serum aldosterone level in a normal patient, whereas the level will not be altered in a Conns patient.  Its effects on increasing Na+ levels, and therefore blood volume, make it useful as an off label treatment for postural orthostatic tachycardia syndrome (POTS)<ref>{{cite journal |author=Freitas J, Santos R, Azevedo E, Costa O, Carvalho M and Falcão de Freitas A|url=http://dx.doi.org/10.1007/BF02281112|title=Clinical improvement in patients with orthostatic intolerance after treatment with bisoprolol and fludrocortisone|journal=Clinical Autonomic Research|volume=10|number=5|year=2000|doi=10.1007/BF02281112|pages=293–299}}</ref>

==Dosing==
Fludrocortisone is available in 0.1 mg tablets. Typical daily doses for mineralocorticoid replacement are between 0.05 mg - 0.2 mg. Renin plasma, sodium, and potassium is checked through blood tests in order to verify that the correct dosage is reached.  

==Chemical properties==
Chemically, fludrocortisone is identical to [[cortisol]] except for the substitution of fluorine in place of one hydrogen. Fluorine is a good [[bioisostere]] for hydrogen because it is similar in size. The major difference is in its [[electronegativity]].

==Side effects==
* Sodium and water retention
* Swelling due to fluid retention ([[edema]])
* High blood pressure ([[hypertension]])
* Headache
* Low blood potassium level ([[hypokalemia]])
* Muscle weakness
* Fatigue
* Increased susceptibility to infection
* Impaired wound healing
* Increased sweating
* Increased hair growth ([[hirsutism]])
* Thinning of skin and stretch marks
* Disturbances of the gut such as indigestion ([[dyspepsia]]), distention of the abdomen and ulceration ([[peptic ulcer]])
* Decreased bone density and increased risk of fractures of the bones
* Difficulty in sleeping ([[insomnia]])
* Depression
* Weight gain
* Raised blood sugar level
* Changes to the menstrual cycle
* Partial loss of vision due to opacity in the lens of the eye ([[cataracts]])
* Raised pressure in the eye ([[glaucoma]])
* Increased pressure in the skull ([[intracranial pressure]])

==References==
{{Reflist}}

{{Corticosteroids}}
{{Glucocorticoids}}
{{Mineralocorticoids}}

[[Category:Mineralocorticoids]]
[[Category:Organofluorides]]